Drawing for VYKINLEO

USPTO serial 79293526

VYKINLEO

Reviewed by CopyMark Law Group

Reg. 6253862Status 711
Filing date
Status date
Registration date
Jan 26, 2021
Examiner
BHUPATHI, TARA
Law office
Historical data usage

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VYKINLEO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER, PLLC3724 BENSON DRRALEIGH, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 7(e) - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 26, 2026NCS7NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED—
Oct 26, 2026C7..CANCELLED SECTION 7-TOTAL—
Oct 19, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 2, 2026C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED—
Sep 2, 2026ES7STEAS SECTION 7 SURRENDER RECEIVED—
Jan 26, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 11, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Aug 11, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 14, 2021CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
May 10, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 1, 2021APETASSIGNED TO PETITION STAFF—
Mar 29, 2021ES7RTEAS SECTION 7 REQUEST RECEIVED—
Mar 20, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 2, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 1, 2021FIMPFINAL DISPOSITION PROCESSED—
Feb 25, 2021GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 26, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 14, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 10, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2020DOCKASSIGNED TO EXAMINER—
Oct 2, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 2, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 2, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 29, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 25, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 21, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 17, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance